To evaluate the tumor-forming ability of KIF11 in vivo, human GBC xenografts were established by subcutaneous injection of approximately 1x106 KIF11-silenced NOZ cells and negative control cells into the left axillary area of nude mice. This evidence concerns the gene KIF11 and neoplasm.